Pharmacists in Mishawaka, Indiana


61 Pharmacists found in Mishawaka
male pharmacist

Mike Thompson


Pharmacist
5020 Grape Rd, Mishawaka, IN 46545
574-273-3520    

female pharmacist

Miranda Macfarlane, PHARMD


Pharmacist
611 E Douglas Rd Ste 407, Mishawaka, IN 46545
574-335-5000    

female pharmacist

Dr. Monica A Rivers, PHARMD, MBA


Pharmacist
420 W 4th St, Mishawaka, IN 46544
574-307-7673    



female pharmacist

Ramandeep Sohi, PHARMD, MBA


Pharmacist
5020 Grape Rd, Mishawaka, IN 46545
574-273-3510    

female pharmacist

Rebecca Collester


Pharmacist
5020 Grape Rd, Mishawaka, IN 46545
574-273-3510    

male pharmacist

Reginald Wensel, R.PH.


Pharmacist
611 E Douglas Rd Ste 104, Mishawaka, IN 46545
574-247-1000    

male pharmacist

Dr. Rithisak Seth, PHARMD


Pharmacist
210 N Main St, Mishawaka, IN 46544
574-259-1130    

male pharmacist

Simon Chen, RPH


Pharmacist
210 N Main St, Mishawaka, IN 46544
574-259-1130     574-257-7920

female pharmacist

Stephanie Mcafee, PHARMD, RPH


Pharmacist
611 E Douglas Rd Ste 407, Mishawaka, IN 46545
574-335-0001    

female pharmacist

Stephanie H Mahler, RPH


Pharmacist
316 Indian Ridge Blvd, Mishawaka, IN 46545
574-243-9707     574-243-9807

male pharmacist

Dr. Theodore J Lingenfelter, PHARMD


Pharmacist - Pharmacotherapy
3610 Bremen Hwy, Mishawaka, IN 46544
574-254-2510     574-254-2565

female pharmacist

Victoria Kumfer


Pharmacist
316 Indian Ridge Blvd, Mishawaka, IN 46545
574-243-9707    

female pharmacist

Yassmeen Marzuq


Pharmacist
611 E Douglas Rd Ste 412, Mishawaka, IN 46545
574-237-7637    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.